Loading…
Based on limited metadata, the FDA issued a Warning Letter to Atomixx, a dietary supplement company, on April 10, 2019. Without access to the full letter text or specific subject line, the precise nature of the violations cannot be detailed from the available information. The warning falls under FDA's regulatory authority over dietary supplements, though the specific issuing office is not identified in the metadata provided. To understand the exact compliance issues cited, review of the complete Warning Letter would be necessary.